100
Participants
Start Date
January 31, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
May 31, 2012
Oncotype DX breast cancer test
The Oncotype DX breast cancer test measures the expression of 21 genes of an individual tumor to generate an Recurrence Score result that quantifies the magnitude of chemotherapy benefit and the likelihood of recurrence for early-stage breast cancer patients.
Centre Azuréen de Cancérologie, Mougins
CHRU Besançon, Besançon
Centre Val d'Aurelle, Montpellier
Centre d'Oncologie Médicale de Gentilly, Nancy
Centre Jean Perrin, Clermont-Ferrand
Hôpital TENON, Paris
Lead Sponsor
Registrat-Mapi
OTHER
Genomic Health®, Inc.
INDUSTRY